化合物C188-9 T4650
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 432001-19-9 | ¥9,870.00 | 询底价 |
50 mg | 432001-19-9 | ¥3,520.00 | 询底价 |
5 mg | 432001-19-9 | ¥828.00 | 询底价 |
100 mg | 432001-19-9 | ¥4,890.00 | 询底价 |
1 mg | 432001-19-9 | ¥348.00 | 询底价 |
2 mg | 432001-19-9 | ¥491.00 | 询底价 |
10 mg | 432001-19-9 | ¥996.00 | 询底价 |
1 mL | 432001-19-9 | ¥913.00 | 询底价 |
25 mg | 432001-19-9 | ¥2,230.00 | 询底价 |
Product Introduction
Bioactivity
英文名: C188-9
描述: C188-9 (TTI-101) 是一种Stat3抑制剂,其Kd 值为 4.7 nM。它诱导 AML 细胞系和原代标本凋亡,抑制原代 AML 细胞集落形成。它抑制 G-CSF 诱导的 STAT3 激活和 STAT3 依赖性基因表达。
体外活性: 在凋亡研究中,AML细胞株和原始样本经C188-9处理24小时后,通过FACS分析量化标记Annexin V的细胞来确定凋亡细胞的数量。凋亡诱导的EC50值变化较大,范围从6 μM到超过50 μM不等。
体内活性: Of the approximately 13,528 discernible genes, levels of 37 gene transcripts are altered by C188 (17 down and 20 up-regulated, fdr<0.01, fold change≥1.5), of which 7 are known STAT3 gene targets. By contrast, C188-9 affects a much greater number of genes involved in oncogenesis (384 total, 95 down- and 289 up-regulated), including 76 genes previously reported as regulated by STAT3 (38 down-regulated and 38 up-regulated). Among the 38 genes previously shown to be upregulated by STAT3, 24 (63%) genes are downregulated by C188-9 treatment, as expected. Additionally, 10 more genes downregulated by C188-9 (fdr <0.01, fold change≥1.5) that previously are shown to be upregulated by STAT1. Thus, 40 of 48 (83.3%) genes downregulated by C188-9 previously are shown to be positively regulated by STAT1, including sixteen genes shown to be co-regulated by STAT3 and STAT1. This analysis raises the possibility that the effect of C188-9 on gene transcript levels in HNSCC tumors is mediated by its effects on both STAT3 and STAT1[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/mL (127.25 mM)
关键字: C1889 | Apoptosis | STAT | TTI101 | Inhibitor | C188 9 | C-188-9 | C188-9 | inhibit | TTI 101
相关产品: APE1-IN-2 | Novobiocin | Ac-IETD-CHO | Azadirachtin | Polyphyllin II | Niraparib hydrochloride | Domatinostat tosylate | Pladienolide B | TAS6417 | Puerarin 6''-O-Xyloside
相关库: Drug Repurposing Compound Library | Anti-Prostate Cancer Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Cancer Cell Differentiation Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | Anti-Pancreatic Cancer Compound Library | Target-Focused Phenotypic Screening Library
化合物C188-9 T4650信息由TargetMol中国为您提供,如您想了解更多关于化合物C188-9 T4650报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途